(Q35078765)

6 August 2017

1 reference

title

TP53 mutations in familial breast cancer: functional aspects (English)

1 reference

6 August 2017

Milena Gasco

1

1 reference

6 August 2017

Isik G Yulug

series ordinal

2

1 reference

6 August 2017

Tim Crook

series ordinal

3

1 reference

6 August 2017

publication date

1 March 2003

1 reference

6 August 2017

1 reference

6 August 2017

volume

21

1 reference

6 August 2017

issue

3

1 reference

6 August 2017

page(s)

301-306

1 reference

p53 mutants have selective dominant-negative effects on apoptosis but not growth arrest in human cancer cell lines

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10173

7 January 2021

TP53 and breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10173

7 January 2021

p53 mutants can often transactivate promoters containing a p21 but not Bax or PIG3 responsive elements

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10173

7 January 2021

Transcriptional activation by p53 correlates with suppression of growth but not transformation.

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10173

7 January 2021

p53 mutation with frequent novel condons but not a mutator phenotype in BRCA1- and BRCA2-associated breast tumours

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10173

7 January 2021

p53 mutation as a genetic trait of typical medullary breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10173

7 January 2021

The p53 proto-oncogene can act as a suppressor of transformation

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10173

7 January 2021

The p53 pathway in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10173

7 January 2021

The tumor suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10173

7 January 2021

Partial rescue of Brca1 (5-6) early embryonic lethality by p53 or p21 null mutation.

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10173

7 January 2021

p53: puzzle and paradigm

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10173

7 January 2021

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10173

7 January 2021

Tumour p53 mutations exhibit promoter selective dominance over wild type p53.

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10173

7 January 2021

Somatic mutations in the p53 gene and prognosis in breast cancer: a meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10173

7 January 2021

Frequency of p53 mutations in breast carcinomas from Ashkenazi Jewish carriers of BRCA1 mutations

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10173

7 January 2021

Increased frequency ofTP53 mutations inBRCA1 andBRCA2 ovarian tumours

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10173

7 January 2021

Specific loss of apoptotic but not cell-cycle arrest function in a human tumor derived p53 mutant

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10173

7 January 2021

ASPP proteins specifically stimulate the apoptotic function of p53

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10173

7 January 2021

p53 mutations in BRCA1-associated familial breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10173

7 January 2021

Novel p53 mutants selected in BRCA-associated tumours which dissociate transformation suppression from other wild-type p53 functions.

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10173

7 January 2021

Brca2 is required for embryonic cellular proliferation in the mouse

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10173

7 January 2021

Kinetics of p53 binding to promoter sites in vivo

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10173

7 January 2021

Surfing the p53 network

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10173

7 January 2021

Live or let die: the cell's response to p53

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10173

7 January 2021

Evolutionary conservation and somatic mutation hotspot maps of p53: correlation with p53 protein structural and functional features.

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10173

7 January 2021

Identification of the breast cancer susceptibility gene BRCA2

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10173

7 January 2021

Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation.

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10173

7 January 2021

BRCA1 physically associates with p53 and stimulates its transcriptional activity.

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10173

7 January 2021

Accumulation of p53 protein is frequent in ovarian cancers associated with BRCA1 and BRCA2 germline mutations

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10173

7 January 2021

Identifiers

DOI

10.1002/HUMU.10173

1 reference

6 August 2017

1 reference